通心络胶囊、六味地黄丸与美多巴合用治疗帕金森病  

Parkinson’s Disease Treated with Tongxinluo Capsule,Liuwei Rehmannia Root Pill and Madopar

作　　者：沈涌[1] 罗烈岚[1] 

机构地区：[1]浙江中医药大学附属广兴医院,杭州310006

出　　处：《浙江中医药大学学报》2008年第2期197-198,共2页Journal of Zhejiang Chinese Medical University

摘　　要：[目的]观察中成药通心络胶囊、六味地黄丸与美多巴合用治疗帕金森病的疗效。[方法]将60例患者随机分两组,治疗组30例在服用美多巴片基础上加服通心络胶囊与六味地黄丸,对照组仅服用美多巴片。治疗前、治疗3个月及6个月后用帕金森病统一评分量表第3分量表(UPDRS subscale Ⅲ)对两组评分、比较。[结果]治疗组治疗前后评分差异无显著性,对照组治疗前与治疗6个月后评分差异有显著性,治疗前低于治疗后;两组治疗6个月后评分差异有显著性,治疗组低于对照组。[结论]中西医结合治疗帕金森病有延缓病情进展的作用。[Objective] To observe the cure effect of Tongxinluo Capsule, Liuwei Rehmannia Root Pill and Madopar in combination on Parkinson＇s disease. [Method] Randomly divide 60 cases into 2 groups, the treatment group 30 cases take Tongxinluo Capsule and Liuwei Rehmannia Root Pill on the basis of Madopar;the control one only Madopar. Evaluate and compare both groups at UPDRS subscale Ⅲ before treatment,3 months and 6 months after treatment. [Result] For the treatment group,there＇s no marked difference between before and after treatment; for the control one, there＇s marked difference between before treatment and 6 months after treatment, the score was lower before than after treatment;obvious difference between both groups after 6 months of treatment, the treatment group was lower than the control one. [Conclusion] Combination of TCM and western medicine can delay the developments of the Parkinson＇s disease.

关 键 词：帕金森病 通心络胶囊 六味地黄丸 美多巴 

分 类 号：R749[医药卫生—神经病学与精神病学]